Theoretical capacities derived from existing regulatory guidance are compared against those determined from experimental investigations, showing that slender RC walls have load capacities significantly higher than the estimates based on current design equations.
Given the absence of current best practice guidance, the intervention was compared solely against the 'measurement only' control condition from the RCT.
For PRO measures supporting claims, a targeted literature review was conducted to identify information on key characteristics and measurement properties; this information was compared against FDA PRO guidance criteria.
The feasibility of the new guidance law is exemplified through computer simulations and the guidance performance is compared with augmented proportional navigation guidance law, sliding mode guidance law and nonsingular terminal sliding mode guidance law.
The performance of the guidance algorithm is compared with other existing guidance algorithms, such as pure pursuit guidance and proportional navigation guidance by simulation based on the dynamic model of HUG.
Barbieri and colleagues (2009) reviewed decisions on 25 cases where NICE and SMC guidances could be compared and found general agreement in terms of recommendations for use in 23 cases.
Numerical simulations are performed to validate the performance of the proposed guidance law, and are compared with that of pure error dynamics-based guidance law.
The effectiveness of both guidance strategies will be compared on the use of ergonomic measures, work ability, physical functioning, limitations due to physical problems of individual construction workers, a process evaluation and a cost-benefit evaluation.
Having annotated the skin with a sterile marker pen under HoloLens guidance, the target positions were compared to the sites of the perforator vessels as subsequently identified by audible Doppler ultrasound and surgical appearances.
According to the FDA guidance, new insulins should be compared with a standard insulin (and not placebo or a non-insulin agent) in clinical trials 1.
